Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Eargo

company

About

Eargo is intended for people who have mild to moderate hearing loss.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$29.30M
Industries
Audio,Health Care,Medical Device,Wearables
Founded date
Jan 1, 2010
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:EAR
Legal Name
Eargo Hearing, Inc.

Eargo is intended for people who have mild to moderate hearing loss..The company also offers online hearing screenings and virtual support, so customers don’t need to have an in-person visit. It offers a rechargeable hearing aids that can be controlled with a smartphone. Its innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility, and cost.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
11
$512.77M
Eargo has raised a total of $512.77M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 29, 2022 Post-IPO Equity $29.30M Detail
Jun 27, 2022 Post-IPO Debt $125M 1 Patient Square Capital Detail
Oct 15, 2020 IPO $141.30M Detail
Jul 29, 2020 Series E $81.57M 5 Gilde Healthcare
Longitude Capital
Detail
Mar 5, 2019 Series D $52M 5 Future Fund Detail

Employee Profiles

Number of Employee Profiles
19
Eargo has 19 current employee profiles, including Executive Daniel Shen
Executive
Executive
Executive
Advisor
Employee